• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Up0.22%

    Valeant Pharmaceuticals International, Inc. (VRX)

    87.09 Up 0.07(0.08%) Nov 27, 1:00PM EST
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income 913,500   (866,100) (116,000)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,807,600  2,105,300  1,022,600  
    Adjustments To Net Income243,300  178,600  3,300  
    Changes In Accounts Receivables(572,400)(300,600)(175,800)
    Changes In Liabilities188,600  (76,500)(8,400)
    Changes In Inventories(174,300)(122,700)(80,300)
    Changes In Other Operating Activities(110,300)121,500  11,200  
    Total Cash Flow From Operating Activities 2,294,700   1,042,000   656,600  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(291,600)(115,300)(107,600)
    Investments(18,800)17,000  617,600  
    Other Cash flows from Investing Activities210,700  (5,282,000)(3,475,700)
    Total Cash Flows From Investing Activities (99,700) (5,380,300) (2,965,700)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock17,200  2,261,800  (257,700)
    Net Borrowings(2,264,400)2,055,700  3,474,700  
    Other Cash Flows from Financing Activities(158,400)(197,700)(139,000)
    Total Cash Flows From Financing Activities (2,443,700) 4,027,700   3,057,300  
    Effect Of Exchange Rate Changes(29,000)(5,200)3,800  
    Change In Cash and Cash Equivalents (277,700) (315,800) 752,000  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.